In another study, by measuring the NRF2 activity in silico and performing its validation in patient samples, the authors showed that NRF2 pathway is upregulated in colon cancer and that such high NRF2 expression associates with patients’ poor prognosis [110]. Here, NFE2L2 is linked to colonic neoplasm.